InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: None

Friday, 11/27/2020 10:54:56 PM

Friday, November 27, 2020 10:54:56 PM

Post# of 198600
Here's a premonition that I believe is both reasonable and conservative to expect near term over the course of the next 30 to 90 days (i.e. by end of Feb 2021)

IMO

1. All filings current

2). Merger finalized (valuation increases significantly here)

PPS= 0.10-0.35

3). Initial funding in place

4). Studies underway at Texas A&M

5). Expansion of Clone-3 testing to neutralize Covid-19 for Fast Track by FDA via Phase III Trial that will likely be conducted in tandem with a HIV Phase III Trial (keep in mind that Protheragen has already taken Clone-3 through the "Pre-Clinical" Phase and may have possibly completed both Phase I & 2 by now although their website doesn't show this)

6). Primate Studies initiated at U.C. Davis

PPS= 0.50-1.50

7). Transition to Phase IV clinical trials (both HIV & Covid-19)

8). Additional funding (multiple sources)

PPS = 1.55-2.00

9). Big Pharma Partner name for global commercialization

PPS= 2.50-5.00

Again, this is ONLY an Opinion nothing else!

I invite any and all feedback on the time line of these events, and/or others, with corresponding estimated PPS. Also, if I missed something, please let me know.

Be well and prosper...